Dan Pugh

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody-Associated Vasculitis.
  Kidney international reports 2025 DOI: 10.1016/j.ekir.2025.04.030
  +Save
• Conquering immunological barrier- part 2: paired kidney exchange transplantation
  Sri Lanka Journal of Surgery 2025 DOI: 10.4038/sljs.v42i3.9186
  +Save
• 18F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitis.
  Nature communications 2024 DOI: 10.1038/s41467-024-51613-1
  +Save
• Choroidalyzer: An Open-Source, End-to-End Pipeline for Choroidal Analysis in Optical Coherence Tomography.
  Investigative ophthalmology & visual science 2024 DOI: 10.1167/iovs.65.6.6
  +Save
• Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment.
  Nature communications 2023 DOI: 10.1038/s41467-023-43125-1
  +Save
• An Open-Source Deep Learning Algorithm for Efficient and Fully Automatic Analysis of the Choroid in Optical Coherence Tomography.
  Translational vision science & technology 2023 DOI: 10.1167/tvst.12.11.27
  +Save
• Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
  Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink +97 more
  Lancet (London, England) 2023 DOI: 10.1016/s0140-6736(23)02302-4
  +Save
• Evaluation of an Automated Choroid Segmentation Algorithm in a Longitudinal Kidney Donor and Recipient Cohort.
  Translational vision science & technology 2023 DOI: 10.1167/tvst.12.11.19
  +Save
• Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
  Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers +97 more
  Lancet (London, England) 2023 DOI: 10.1016/s0140-6736(23)00569-x
  +Save
• Percutaneous Intervention in Takayasu Arteritis: Potential Advantages of Procedural Perseverance.
  Journal of the American College of Cardiology 2023 DOI: 10.1016/j.jacc.2022.11.009
  +Save
• Endothelin blockade prevents the long-term cardiovascular and renal sequelae of acute kidney injury in mice.
  Science translational medicine 2022 DOI: 10.1126/scitranslmed.abf5074
  +Save
• Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study.
  The European respiratory journal 2022 DOI: 10.1183/13993003.03168-2021
  +Save
• Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.
  Kidney international 2022 DOI: 10.1016/j.kint.2022.06.019
  +Save
• Utility of interval kidney biopsy in ANCA-associated vasculitis.
  Rheumatology (Oxford, England) 2022 DOI: 10.1093/rheumatology/keab695
  +Save
• Comment on: A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG PET/CT: a Chinese cohort study.
  Rheumatology (Oxford, England) 2022 DOI: 10.1093/rheumatology/keab802
  +Save
• Large-vessel vasculitis.
  Dan Pugh, Maira Karabayas, Neil Basu +10 more
  Nature reviews. Disease primers 2022 DOI: 10.1038/s41572-021-00327-5
  +Save
• Interventions for atypical haemolytic uraemic syndrome.
  The Cochrane database of systematic reviews 2021 DOI: 10.1002/14651858.cd012862.pub2
  +Save
• Aortitis: recent advances, current concepts and future possibilities.
  Heart (British Cardiac Society) 2021 DOI: 10.1136/heartjnl-2020-318085
  +Save
• Hypertension and Vascular Inflammation: Another Piece of the Genetic Puzzle.
  Hypertension (Dallas, Tex. : 1979) 2020 DOI: 10.1161/hypertensionaha.120.16420
  +Save
• Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease.
  Nephrology (Carlton, Vic.) 2020 DOI: 10.1111/nep.13844
  +Save